The present study provides new information on the potential of paeonol treatment in the prevention of VSMC senescence and atherosclerosis and suggests that paeonol may be a promising candidate as a SIRT1 agonist for the treatment of atherosclerosis. Here, SIRT1 is linked to atherosclerosis.